Valsalakumari, R.; Feith, M.; Pettersen, S.; Åslund, A.K.O.; Mørch, Ý.; Skotland, T.; Sandvig, K.; Mælandsmo, G.M.; Iversen, T.-G.
Combinatorial Effects of Free and Nanoencapsulated Forms of Cabazitaxel and RAS-Selective Lethal 3 in Breast Cancer Cells. Pharmaceutics 2025, 17, 657.
https://doi.org/10.3390/pharmaceutics17050657
AMA Style
Valsalakumari R, Feith M, Pettersen S, Åslund AKO, Mørch Ý, Skotland T, Sandvig K, Mælandsmo GM, Iversen T-G.
Combinatorial Effects of Free and Nanoencapsulated Forms of Cabazitaxel and RAS-Selective Lethal 3 in Breast Cancer Cells. Pharmaceutics. 2025; 17(5):657.
https://doi.org/10.3390/pharmaceutics17050657
Chicago/Turabian Style
Valsalakumari, Remya, Marek Feith, Solveig Pettersen, Andreas K. O. Åslund, Ýrr Mørch, Tore Skotland, Kirsten Sandvig, Gunhild Mari Mælandsmo, and Tore-Geir Iversen.
2025. "Combinatorial Effects of Free and Nanoencapsulated Forms of Cabazitaxel and RAS-Selective Lethal 3 in Breast Cancer Cells" Pharmaceutics 17, no. 5: 657.
https://doi.org/10.3390/pharmaceutics17050657
APA Style
Valsalakumari, R., Feith, M., Pettersen, S., Åslund, A. K. O., Mørch, Ý., Skotland, T., Sandvig, K., Mælandsmo, G. M., & Iversen, T.-G.
(2025). Combinatorial Effects of Free and Nanoencapsulated Forms of Cabazitaxel and RAS-Selective Lethal 3 in Breast Cancer Cells. Pharmaceutics, 17(5), 657.
https://doi.org/10.3390/pharmaceutics17050657
